BLT.AX - Benitec Biopharma Limited

ASX - ASX Delayed Price. Currency in AUD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/2017
Total Revenue11,093
Cost of Revenue272
Gross Profit10,821
Operating Expenses
Research Development-
Selling General and Administrative-
Non Recurring-
Others-
Total Operating Expenses16,510
Operating Income or Loss-5,417
Income from Continuing Operations
Total Other Income/Expenses Net-
Earnings Before Interest and Taxes-5,417
Interest Expense-
Income Before Tax-
Income Tax Expense-
Minority Interest-
Net Income From Continuing Ops-
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect Of Accounting Changes-
Other Items-
Net Income
Net Income-5,690
Preferred Stock And Other Adjustments-
Net Income Applicable To Common Shares-